Table 2.
Analysis of the diagnostic performance of TpN17 and TmpA antigens in the phase II study, considering serial, and parallel analyses.
| Performance parameters | Serial | Parallel | ||
|---|---|---|---|---|
| Values | 95% CI | Values | 95% CI | |
| Sensitivity (%) | 91.1 | 86.0–94.5 | 97.2 | 93.7–98.8 |
| Specificity (%) | 99.5 | 97.1–99.9 | 100 | 98–100 |
| Accuracy (%) | 95.4 | 92.8–97.1 | 98.7 | 96.9–99.4 |
95% CI, confidence interval to 95%.